Skip to content

Clinical trials

Phase 1/2 Neoplasm Metastasis trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Phase: Phase 1/2 Country / region: Taiwan Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20131
20161
20171
20191
20204
20213
20224
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting5
Terminated5
Completed4
Active, not recruiting3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC3
Ascendis Pharma Oncology Division A/S2
AstraZeneca2
Nuvalent Inc.2
DualityBio Inc.1
Imugene Limited1
Incyte Corporation1
Kymab Limited1
Novartis Pharmaceuticals1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis18
Carcinoma, Non-Small-Cell Lung7
Lung Neoplasms3
Gastrointestinal Neoplasms2
Neoplasms2
Recurrence2
Stomach Neoplasms2
Uterine Cervical Neoplasms2
Adenocarcinoma1
Bile Duct Neoplasms1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.